MRI Interventions, Inc. (MRIC)
-OTC BB 1.18 0.00(0.00%) 2:03PM EDT
| Prev Close: | 1.18 |
|---|
| Open: | 1.18 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 3.50 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.11 - 1.20 |
|---|
| 52wk Range: | 0.75 - 5.00 |
|---|
| Volume: | 32,800 |
|---|
| Avg Vol (3m): | 114,658 |
|---|
| Market Cap: | 64.73M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.07 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- MRI INTERVENTIONS, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Three of WellPoint's directors resign for personal reasonsat Reuters(Mon, May 13)
- MRI INTERVENTIONS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- MRI Interventions' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- MRI Interventions Announces First Quarter 2013 Financial ResultsGlobeNewswire(Thu, May 9)
- MRI INTERVENTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,EDGAR Online(Thu, May 9)
- MRI Interventions' ClearPoint Neuro Intervention System to be Featured as Drug Delivery Platform at 2013 Annual Targeted Drug Delivery ConferenceGlobeNewswire(Fri, May 3)
- MRI Interventions to Report First Quarter 2013 Financial ResultsGlobeNewswire(Mon, Apr 29)
- MRI Interventions Exhibiting Its Advanced Neurosurgical Navigation Platform, the ClearPoint Neuro Intervention System, at AANS 2013 Annual MeetingGlobeNewswire(Mon, Apr 29)
- MRI Interventions' ClearPoint(R) System Helps Advance Brain Cancer Clinical Trial of Investigational Gene Therapy Drug Toca 511, Demonstrates Benefits of MRI-Guided Drug DeliveryGlobeNewswire(Thu, Apr 25)
- Advances in Healthcare: Delivery of Minimally-Invasive Therapies in the Brain Using Interventional MRI Guidance Highlighted During ISMRM 2013 Interventional MR Study GroupGlobeNewswire(Mon, Apr 22)
- MRI Interventions Elects Dr. Philip A. Pizzo to Board of DirectorsGlobeNewswire(Tue, Apr 16)
- MRI INTERVENTIONS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, FinaEDGAR Online(Tue, Apr 16)
- MRI Interventions' ClearPoint System Used by Physicians in Laser Ablation Procedures for Patients with Epilepsy and Brain TumorPR Newswire(Tue, Apr 2)
- Deep Brain Stimulation (DBS) with ClearPoint® Neuro Intervention System Featured on Fox News Health OnlinePR Newswire(Thu, Mar 28)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 12.12 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.13 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.04 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | -0.33 |
|---|
Business Summary
MRI Interventions, Inc., a medical device company, develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance primarily in t...
View More 
0.34%